TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
TGTX

TG Therapeutics Inc

Healthcare · Biotechnology

53.00$ +1.5% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

TG Therapeutics Inc (TGTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,640 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TGTX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
76 55 123 101 102 97 121 141 114 84 118 107 93 163 102 295 274 626 549 481 410 380 303 252 218 194 197 221 331 330 373 401 586 578 657 703 1,025 1,063 1,529 1,640
71 51 119 97 98 93 117 136 110 79 105 94 80 149 88 281 260 612 535 455 372 331 242 203 183 168 185 145 319 318 361 389 574 566 645 664 600 631 1,087 1,146
29 25 96 78 92 57 83 106 71 42 64 57 45 113 52 261 254 553 472 402 327 299 186 147 110 102 61 97 151 93 75 83 196 180 132 129 74 79 442 483
61 45 109 86 92 85 109 126 98 69 92 85 72 140 78 276 254 605 524 443 357 315 233 196 176 162 140 145 229 218 210 217 341 311 276 252 132 142 514 552
0.1 0.1 0.0 0.0 – 0.1 0.1 0.1 0.1 0.1 0.1 – – – – – – – 0.8 0.9 1.4 1.4 0.9 0.1 0.0 0.0 8.6 17 39 51 65 84 116 129 190 232 265 306 392 402
10 5.6 8.4 9.7 0.0 7.9 6.8 8.8 11 9.7 – – – – – – – – 5.6 -5.0 -14 -24 4.1 -32 – 0.0 27 30 34 40 78 81 85 110 158 155 147 126 129 148
0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.3 0.3 0.3 0.3 0.4 0.5 0.5 9.6 0.6 0.6 0.5 0.4 0.4 0.3 0.2 0.2 – – – – – – – – – – – –
0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 – – – – – – – –
0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
76 55 123 23 22 97 36 141 43 60 98 93 119 124 103 100 103 106 103 98 98 142 133 123 117 135 170 180 166 169 213 224 394 355 419 426 418 415 946 1,036
17 17 20 21 20 28 33 37 40 39 61 56 80 84 63 68 78 88 92 88 88 65 55 43 36 53 63 73 58 54 100 109 125 91 160 172 157 154 187 268
0.1 0.1 0.2 -20 0.2 0.1 0.2 0.2 0.1 -39 1.4 -32 -33 1.6 1.6 8.9 16 24 32 25 17 2.4 1.5 1.5 1.6 1.6 1.5 1.5 1.5 1.4 1.4 1.3 1.2 1.2 1.1 1.1 1.9 1.0 1.8 1.9
16 15 19 20 18 26 33 35 38 36 39 31 32 30 31 30 35 37 43 40 45 51 48 37 30 42 57 63 40 38 87 93 101 58 134 134 112 108 149 214
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 28 29 29 29 29 22 15 7.7 – – – 67 67 69 70 71 97 98 99 100 101 103 244 244 245 245 245 246 745 745
57 36 101 78 80 67 85 101 72 24 19 13 -662 39 -1.4 194 171 519 445 383 312 237 170 129 100 59 -1,566 -1,614 165 161 160 178 192 222 237 276 607 648 583 604
-213 -236 -264 -292 -324 -355 -396 -441 -474 -528 -564 -600 -662 -701 -752 -805 -892 -981 -1,071 -1,150 -1,235 -1,329 -1,398 -1,438 -1,474 -1,527 -1,566 -1,614 -1,500 -1,553 -1,525 -1,556 -1,553 -1,529 -1,524 -1,496 -1,105 -1,082 -1,062 -1,054
49 49 53 63 65 67 71 72 78 81 81 87 90 96 105 112 119 124 132 132 132 133 134 138 135 137 140 142 156 143 146 159 161 160 163 163 161 159 160 157

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?